As of Monday, July 24, Aurora Cannabis Inc. will commence trading of common shares on the Toronto Stock Exchange (TSX) under the trade symbol “ACB”. In conjunction with listing on TSX, the common shares have been voluntarily delisted from TSX Venture Exchange, effective close of trading today, Friday, July 21, 2017.
Aurora will “ring the bell” to open TSX on Monday, July 24, 2017.
According to Terry Booth CEO of Aurora, the company has been achieving record yields at their Mountain View County production facility, progressing rapidly with the construction of their 100,000+ kg per annum Aurora Sky facility at Edmonton International Airport, and are executing consistently on their national and international expansion strategy.
“Aurora’s graduation to TSX reflects the remarkable commercial and operational progress we have made since listing on TSX Venture Exchange late last year,” said Booth. “The acquisition of our third production facility, in Pointe-Claire, will further support our domestic growth. Our acquisition of Pedanios, Germany’s largest medical cannabis distributor, and our strategic investment in Australia’s Cann Group, have established Aurora as a global leader in the cannabis sector. Aurora continues to drive innovation in the industry, as evidenced by our research collaboration with and investment in Radient Technologies, the launch and upgrades of our one-of-a-kind mobile application, and the expansion of our same-day and next-day delivery program. We expect that graduating to TSX will further increase our shareholder audience, and represents another important strategic step in enhancing shareholder value.”
Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island. In addition, the company is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis, as well as owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union (“EU”), based in Germany. Aurora’s common shares now trade on TSX under the symbol “ACB”.